PT98544A - Processo para a preparacao enzimatica do factor basico do crescimento de fibro-blastos - Google Patents

Processo para a preparacao enzimatica do factor basico do crescimento de fibro-blastos

Info

Publication number
PT98544A
PT98544A PT98544A PT9854491A PT98544A PT 98544 A PT98544 A PT 98544A PT 98544 A PT98544 A PT 98544A PT 9854491 A PT9854491 A PT 9854491A PT 98544 A PT98544 A PT 98544A
Authority
PT
Portugal
Prior art keywords
bfgf
thr
fibro
adduct
enzymatic preparation
Prior art date
Application number
PT98544A
Other languages
English (en)
Other versions
PT98544B (pt
Inventor
Paolo Sarmientos
Pierre Monsan
Francois Paul
Didier Betbeder
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of PT98544A publication Critical patent/PT98544A/pt
Publication of PT98544B publication Critical patent/PT98544B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
PT98544A 1990-08-02 1991-08-01 Processo para a preparacao enzimatica do factor basico do crescimento de fibro-blastos PT98544B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909017008A GB9017008D0 (en) 1990-08-02 1990-08-02 Process for the enzymatic preparation of basic fibroblast growth factor

Publications (2)

Publication Number Publication Date
PT98544A true PT98544A (pt) 1992-06-30
PT98544B PT98544B (pt) 1999-01-29

Family

ID=10680087

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98544A PT98544B (pt) 1990-08-02 1991-08-01 Processo para a preparacao enzimatica do factor basico do crescimento de fibro-blastos

Country Status (27)

Country Link
US (1) US5348863A (pt)
EP (1) EP0495049B1 (pt)
JP (1) JPH05501655A (pt)
KR (1) KR100191697B1 (pt)
CN (1) CN1033810C (pt)
AT (1) ATE152122T1 (pt)
AU (1) AU643822B2 (pt)
CA (1) CA2066174A1 (pt)
CZ (1) CZ286237B6 (pt)
DE (1) DE69125810T2 (pt)
DK (1) DK0495049T3 (pt)
ES (1) ES2103822T3 (pt)
FI (1) FI921428A0 (pt)
GB (1) GB9017008D0 (pt)
GR (1) GR3024111T3 (pt)
HU (1) HU212671B (pt)
IE (1) IE912729A1 (pt)
IL (1) IL98988A (pt)
MY (1) MY107334A (pt)
NO (1) NO301480B1 (pt)
NZ (1) NZ239204A (pt)
PH (1) PH31240A (pt)
PT (1) PT98544B (pt)
RU (1) RU2093519C1 (pt)
WO (1) WO1992002539A1 (pt)
YU (1) YU48309B (pt)
ZA (1) ZA916026B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT67217A (en) * 1992-02-14 1995-03-28 Kaken Pharma Co Ltd Remedy for airway diseases
HU221638B1 (hu) * 1994-04-21 2002-12-28 Leukotech A/S Heparinkötő fehérje alkalmazása szepszis kezelésére szolgáló gyógyszer előállítására
US5939390A (en) * 1995-03-09 1999-08-17 Novo Nordisk A/S Pharmaceutical composition
US6274712B1 (en) 1997-12-23 2001-08-14 3-Dimensional Pharmaceuticals, Inc. Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137
RU2187118C2 (ru) * 2000-07-13 2002-08-10 Российский научно-исследовательский нейрохирургический институт им. проф. А.Л. Поленова Способ диагностики возможности рецидивов церебральных рацемозных артериовенозных мальформаций
IL141647A0 (en) 2001-02-26 2002-03-10 Yeda Res & Dev Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
ATE512674T1 (de) 2003-01-06 2011-07-15 Angiochem Inc Angiopep-1, verwandte verbindungen, und deren verwnedungen
NZ541659A (en) 2003-01-14 2007-05-31 Teva Pharma Pharmaceutical composition comprising with a pH between 4 and 9 to treat SLE comprising an aqueous carrier, a pharmaceutically acceptable salt of a peptide and a substituted beta-cyclodextrin
US8618054B2 (en) 2004-05-05 2013-12-31 Valorisation-Rechereche Société en Commandite Interleukin-1 receptor antagonists, compositions, and methods of treatment
EP1751175B1 (en) 2004-05-05 2012-07-25 VALORISATION-RECHERCHE, Société en Commandite Interleukin-1 receptor antagonists, compositions, and methods of treatment
AU2006264567A1 (en) 2005-05-05 2007-01-11 Valorisation Hsj, Societe En Commandite Cytokine receptor modulators and uses thereof
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
CA2688344C (en) 2007-05-29 2019-09-03 Angiochem, Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
CN102026667B (zh) 2008-04-18 2014-06-25 安吉奥开米公司 紫杉醇、紫杉醇类似物或紫杉醇结合物的药物组合物及相关制备方法和用途
US8828925B2 (en) 2008-10-15 2014-09-09 Angiochem Inc. Etoposide and doxorubicin conjugates for drug delivery
WO2010043047A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Conjugates of glp-1 agonists and uses thereof
WO2010063122A1 (en) 2008-12-05 2010-06-10 Angiochem Inc. Conjugates of neurotensin or neurotensin analogs and uses thereof
EP2373789A4 (en) 2008-12-17 2012-08-29 Angiochem Inc MEMBRANTYP-1 MATRIX METALLOPROTEINASE INHIBITORS AND THEIR USE
RU2011146654A (ru) 2009-04-20 2013-05-27 Ангиокем Инк. Способы лечения рака яичников с применением конъюгированного средства
WO2011000095A1 (en) 2009-07-02 2011-01-06 Angiochem Inc. Multimeric peptide conjugates and uses thereof
EP2588490B1 (en) 2010-07-02 2017-02-22 Angiochem Inc. Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof
SG11201509430WA (en) * 2013-05-16 2015-12-30 Agency Science Tech & Res Heparan sulphates
WO2016080916A1 (en) 2014-11-19 2016-05-26 Agency For Science, Technology And Research Heparan sulphates for use in repair and/or regeneration of skin
WO2016080915A1 (en) 2014-11-19 2016-05-26 Agency For Science, Technology And Research Cosmetic use of heparan sulphate
EP3307326B9 (en) 2015-06-15 2021-02-24 Angiochem Inc. Methods for the treatment of leptomeningeal carcinomatosis
CN105294851B (zh) * 2015-12-07 2019-02-12 中国科学院长春应用化学研究所 与几丁质特异结合的碱性成纤维细胞生长因子及其编码基因、制备方法与应用
CN114965839A (zh) * 2022-05-11 2022-08-30 朗肽生物制药股份有限公司 人碱性成纤维细胞生长因子的肽图分析方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785079A (en) * 1984-11-09 1988-11-15 The Salk Institute For Biological Studies Isolation of fibroblast growth factor
US4956455A (en) * 1984-03-05 1990-09-11 The Salk Institute For Biological Studies Bovine fibroblast growth factor
US5026839A (en) * 1985-12-17 1991-06-25 Synergen, Inc DNA encoding a basic fibroblast growth factor
DE3811921A1 (de) * 1988-04-09 1989-10-19 Hoechst Ag Verfahren zur herstellung von proteinen, die n-terminal mit prolin beginnen
US5136025A (en) * 1990-04-04 1992-08-04 California Biotechnology Inc. Method to purify basic fibroblast growth factor

Also Published As

Publication number Publication date
AU643822B2 (en) 1993-11-25
CN1058597A (zh) 1992-02-12
ES2103822T3 (es) 1997-10-01
PT98544B (pt) 1999-01-29
US5348863A (en) 1994-09-20
YU48309B (sh) 1998-05-15
PH31240A (en) 1998-06-18
JPH05501655A (ja) 1993-04-02
GB9017008D0 (en) 1990-09-19
HU9201101D0 (en) 1992-08-28
NO921236L (no) 1992-03-30
FI921428L (fi) 1992-04-01
IL98988A0 (en) 1992-07-15
AU8304491A (en) 1992-03-02
CA2066174A1 (en) 1992-02-03
NZ239204A (en) 1993-11-25
GR3024111T3 (en) 1997-10-31
RU2093519C1 (ru) 1997-10-20
YU131991A (sh) 1994-05-10
NO301480B1 (no) 1997-11-03
DE69125810T2 (de) 1997-08-07
DE69125810D1 (de) 1997-05-28
EP0495049A1 (en) 1992-07-22
HU212671B (en) 1996-09-30
HUT64564A (en) 1994-01-28
CN1033810C (zh) 1997-01-15
IE912729A1 (en) 1992-02-12
CZ286237B6 (cs) 2000-02-16
NO921236D0 (no) 1992-03-30
MY107334A (en) 1995-11-30
ATE152122T1 (de) 1997-05-15
FI921428A7 (fi) 1992-04-01
DK0495049T3 (da) 1997-08-25
KR100191697B1 (ko) 1999-06-15
ZA916026B (en) 1992-04-29
KR920702371A (ko) 1992-09-03
EP0495049B1 (en) 1997-04-23
WO1992002539A1 (en) 1992-02-20
CS236291A3 (en) 1992-02-19
FI921428A0 (fi) 1992-04-01
IL98988A (en) 1997-02-18

Similar Documents

Publication Publication Date Title
DK0495049T3 (da) Fremgangsmåde til enzymatisk fremstilling af basal fibroblastvækstfaktor
DE59009414D1 (de) Verfahren zur Herstellung eines Laserwafers.
DE69020794D1 (de) Enzymatische Entfernung einer aminoterminalen Proteinsequenz.
DE59610116D1 (de) Verfahren zur Herstellung von D,L-Methionin oder dessen Alkalisalzen
DE59409751D1 (de) Verfahren zur Herstellung von hydroxyphenylsubstituierten 1,3,5-Triazinen
ES2176456T3 (es) Procedimiento de preparacion de un compuesto inhibidor del vih proteasa.
BR9205163A (pt) Processo para a preparacao de protease alcalina altamente purificada a partir de um caldo de fermentacao,composicao e protease alcalina purificada
DE69433755D1 (de) Verfahren zur Herstellung von Imidazolin abgeleiteten Amphoacetat-Tensiden von höherer Reinheit
DE59409434D1 (de) Verfahren zur Herstellung von Hydroxyphenyl-1,3,5-Triazinen
DE69007800D1 (de) Verfahren zur fermentativen Herstellung von L-Arginin.
MX9301287A (es) Alargaderas o tirantes de acero de alta resistencia y metodos para elaborarlas.
ATE153073T1 (de) Verfahren zur herstellung von n- acetylneuraminsäure
DE59402292D1 (de) Verfahren zur Herstellung von 1,3,5-Triazinen
DE59003697D1 (de) Verfahren zur Herstellung von Chromsäure.
DE69021711D1 (de) Verfahren zur Herstellung von optisch aktiven Hydroxylactonen.
DE69017510D1 (de) Verfahren zur Herstellung von Nylonstapelfasern.
DE69403537D1 (de) Verfahren zur Synthese von halbsynthetischen Glykosaminoglykanen mit Heparin- oder Heparanstruktur, die in 2-Position modifiziertes Alpha-L-Iduronsäure-2-O-Sulfat enthalten
BR9406352A (pt) Processo para a fabricição de ácido aminometanofosfonico
FR2708603B1 (fr) Procédé de préparation d'hydroperoxyde de cumène.
DE59805677D1 (de) Froststabilisierung von wässrigen überzugsmitteln durch frostschutzproteine
DE59003699D1 (de) Verfahren zur Herstellung von Chromsäure.
DE58906998D1 (de) Verfahren zur Herstellung von 4,5,6-Trichlorpyrimidin.
DE59004485D1 (de) Verfahren zur Herstellung von 2-(Methylthio)barbitursäure.
DE59101638D1 (de) Verfahren zur Herstellung von Alkaliphosphatlösungen.
DE59101321D1 (de) Verfahren zur Herstellung von Aminoarylsulfonsäuren.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920207

FG3A Patent granted, date of granting

Effective date: 19981015

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20000430